206 related articles for article (PubMed ID: 15109512)
1. Substance P signaling contributes to the vascular and nociceptive abnormalities observed in a tibial fracture rat model of complex regional pain syndrome type I.
Guo TZ; Offley SC; Boyd EA; Jacobs CR; Kingery WS
Pain; 2004 Mar; 108(1-2):95-107. PubMed ID: 15109512
[TBL] [Abstract][Full Text] [Related]
2. Glucocorticoid inhibition of vascular abnormalities in a tibia fracture rat model of complex regional pain syndrome type I.
Guo TZ; Wei T; Kingery WS
Pain; 2006 Mar; 121(1-2):158-67. PubMed ID: 16472917
[TBL] [Abstract][Full Text] [Related]
3. Acute versus chronic phase mechanisms in a rat model of CRPS.
Wei T; Guo TZ; Li WW; Kingery WS; Clark JD
J Neuroinflammation; 2016 Jan; 13():14. PubMed ID: 26785976
[TBL] [Abstract][Full Text] [Related]
4. Immobilization contributes to exaggerated neuropeptide signaling, inflammatory changes, and nociceptive sensitization after fracture in rats.
Guo TZ; Wei T; Li WW; Li XQ; Clark JD; Kingery WS
J Pain; 2014 Oct; 15(10):1033-45. PubMed ID: 25063543
[TBL] [Abstract][Full Text] [Related]
5. A substance P receptor (NK1) antagonist can reverse vascular and nociceptive abnormalities in a rat model of complex regional pain syndrome type II.
Kingery WS; Davies MF; Clark JD
Pain; 2003 Jul; 104(1-2):75-84. PubMed ID: 12855316
[TBL] [Abstract][Full Text] [Related]
6. TNF signaling contributes to the development of nociceptive sensitization in a tibia fracture model of complex regional pain syndrome type I.
Sabsovich I; Guo TZ; Wei T; Zhao R; Li X; Clark DJ; Geis C; Sommer C; Kingery WS
Pain; 2008 Jul; 137(3):507-519. PubMed ID: 18035493
[TBL] [Abstract][Full Text] [Related]
7. Post-junctional facilitation of Substance P signaling in a tibia fracture rat model of complex regional pain syndrome type I.
Wei T; Li WW; Guo TZ; Zhao R; Wang L; Clark DJ; Oaklander AL; Schmelz M; Kingery WS
Pain; 2009 Aug; 144(3):278-286. PubMed ID: 19464118
[TBL] [Abstract][Full Text] [Related]
8. Substance P spinal signaling induces glial activation and nociceptive sensitization after fracture.
Li WW; Guo TZ; Shi X; Sun Y; Wei T; Clark DJ; Kingery WS
Neuroscience; 2015 Dec; 310():73-90. PubMed ID: 26386297
[TBL] [Abstract][Full Text] [Related]
9. Pentoxifylline attenuates nociceptive sensitization and cytokine expression in a tibia fracture rat model of complex regional pain syndrome.
Wei T; Sabsovich I; Guo TZ; Shi X; Zhao R; Li W; Geis C; Sommer C; Kingery WS; Clark DJ
Eur J Pain; 2009 Mar; 13(3):253-62. PubMed ID: 18554967
[TBL] [Abstract][Full Text] [Related]
10. The role of enhanced cutaneous IL-1beta signaling in a rat tibia fracture model of complex regional pain syndrome.
Li WW; Sabsovich I; Guo TZ; Zhao R; Kingery WS; Clark DJ
Pain; 2009 Aug; 144(3):303-313. PubMed ID: 19473768
[TBL] [Abstract][Full Text] [Related]
11. Oxidative Stress Contributes to Fracture/Cast-Induced Inflammation and Pain in a Rat Model of Complex Regional Pain Syndrome.
Guo TZ; Wei T; Huang TT; Kingery WS; Clark JD
J Pain; 2018 Oct; 19(10):1147-1156. PubMed ID: 29715519
[TBL] [Abstract][Full Text] [Related]
12. Bisphosphonates Inhibit Pain, Bone Loss, and Inflammation in a Rat Tibia Fracture Model of Complex Regional Pain Syndrome.
Wang L; Guo TZ; Hou S; Wei T; Li WW; Shi X; Clark JD; Kingery WS
Anesth Analg; 2016 Oct; 123(4):1033-45. PubMed ID: 27636578
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-NGF antibodies in a rat tibia fracture model of complex regional pain syndrome type I.
Sabsovich I; Wei T; Guo TZ; Zhao R; Shi X; Li X; Yeomans DC; Klyukinov M; Kingery WS; Clark DJ
Pain; 2008 Aug; 138(1):47-60. PubMed ID: 18083307
[TBL] [Abstract][Full Text] [Related]
14. Chronic post-ischemia pain (CPIP): a novel animal model of complex regional pain syndrome-type I (CRPS-I; reflex sympathetic dystrophy) produced by prolonged hindpaw ischemia and reperfusion in the rat.
Coderre TJ; Xanthos DN; Francis L; Bennett GJ
Pain; 2004 Nov; 112(1-2):94-105. PubMed ID: 15494189
[TBL] [Abstract][Full Text] [Related]
15. Keratinocyte expression of inflammatory mediators plays a crucial role in substance P-induced acute and chronic pain.
Wei T; Guo TZ; Li WW; Hou S; Kingery WS; Clark JD
J Neuroinflammation; 2012 Jul; 9():181. PubMed ID: 22824437
[TBL] [Abstract][Full Text] [Related]
16. The NALP1 inflammasome controls cytokine production and nociception in a rat fracture model of complex regional pain syndrome.
Li WW; Guo TZ; Liang D; Shi X; Wei T; Kingery WS; Clark JD
Pain; 2009 Dec; 147(1-3):277-86. PubMed ID: 19853379
[TBL] [Abstract][Full Text] [Related]
17. Substance P signaling controls mast cell activation, degranulation, and nociceptive sensitization in a rat fracture model of complex regional pain syndrome.
Li WW; Guo TZ; Liang DY; Sun Y; Kingery WS; Clark JD
Anesthesiology; 2012 Apr; 116(4):882-95. PubMed ID: 22343473
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of two methods for establishing rat models of complex regional pain syndrome type 1].
Wu R; Li RH
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Dec; 31(12):1985-8. PubMed ID: 22200696
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide deficient mice have attenuated nociceptive, vascular, and inflammatory changes in a tibia fracture model of complex regional pain syndrome.
Guo TZ; Wei T; Shi X; Li WW; Hou S; Wang L; Tsujikawa K; Rice KC; Cheng K; Clark DJ; Kingery WS
Mol Pain; 2012 Nov; 8():85. PubMed ID: 23191958
[TBL] [Abstract][Full Text] [Related]
20. A substance P receptor (NK1) antagonist enhances the widespread osteoporotic effects of sciatic nerve section.
Kingery WS; Offley SC; Guo TZ; Davies MF; Clark JD; Jacobs CR
Bone; 2003 Dec; 33(6):927-36. PubMed ID: 14678852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
